[6-Chloro-9-(4-methoxy-3,5-dimethylpyridin-2-ylmethyl)-9H-purin-2-yl]amine
-
[6-Chloro-9-(4-methoxy-3,5-dimethylpyridin-2-ylmethyl)-9H-purin-2-yl]amine
structure -
-
CAS No:
848695-25-0
-
Formula:
C14H15ClN6O
-
Chemical Name:
[6-Chloro-9-(4-methoxy-3,5-dimethylpyridin-2-ylmethyl)-9H-purin-2-yl]amine
-
Synonyms:
9H-Purin-2-amine,6-chloro-9-[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]-;6-Chloro-9-[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]-9H-purin-2-amine;[6-Chloro-9-(4-methoxy-3,5-dimethylpyridin-2-ylmethyl)-9H-purin-2-yl]amine;BIIB 021;CNF 2024;946090-40-0
- Categories:
-
CAS No:
Description
ChEBI: A member of the class of 2-aminopurines that is 2-aminopurine which is substituted by a chlorine at position 6 and by a (4-methoxy-3,5-dimethylpyridin-2-yl)methyl group at position 9.
BIIB021 is a member of the class of 2-aminopurines that is 2-aminopurine which is substituted by a chlorine at position 6 and by a (4-methoxy-3,5-dimethylpyridin-2-yl)methyl group at position 9. It has a role as a Hsp90 inhibitor and an antineoplastic agent. It is a member of pyridines, a member of 2-aminopurines, an organochlorine compound and an aromatic ether.|BIIB021 has been investigated for the treatment of Tumors and Lymphoma.|Hsp90 Inhibitor BIIB021 is an orally active inhibitor of heat shock protein 90 (HSP90) with potential antineoplastic activity. HSP90, a chaperon protein upregulated in a variety of tumor cells, regulates the folding and degradation of many oncogenic signaling proteins. HSP90 inhibitor BIIB021 specifically blocks active HSP90, thereby inhibiting its chaperon function and promoting the degradation of oncogenic signaling proteins involved in tumor cell proliferation and survival. As a result, CNF2024 has the potential to inhibit the growth of a wide range of cancer cells in both solid tumors and blood-based cancers.
[6-Chloro-9-(4-methoxy-3,5-dimethylpyridin-2-ylmethyl)-9H-purin-2-yl]amine Basic Attributes
318.7615
318.76
-0
851B9FQ7Q0
C62517
2933990090
Safety Information
P261, P264, P271, P280, P302+P352, P304+P340, P305+P351+P338, P312, P321, P332+P313, P337+P313, P362, P403+P233, P405, P501
H315
|Warning|H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation]|P261, P264, P271, P280, P302+P352, P304+P340, P305+P351+P338, P312, P321, P332+P313, P337+P313, P362, P403+P233, P405, and P501|The GHS information provided by 1 company from 1 notification to the ECHA C&L Inventory.
[6-Chloro-9-(4-methoxy-3,5-dimethylpyridin-2-ylmethyl)-9H-purin-2-yl]amine Use and Manufacturing
Weigh respectively 2-amino-6-chloropurine 10mmol, anhydrous potassium carbonate 12mmol, the amount of 25mL DMSO was added to a 50mL round bottom flask, the oil bath was heated to 48 ° C, stirring reaction 30min;11 mmol of 2-chloromethyl-3, 5-dimethylpyridine hydrochloride was weighed and added to the above reaction solution in 3 portions at intervals of 30 minutes.After reacting at 48 °C for 10 h, the temperature was set to 22 °C and stirred for 2 h. After the reaction was completed, the reaction solution was filtered and the filtrate was retained.The volume ratio of water: isopropyl alcohol = 1:1 mixed solution was added to the filtrate, until the solution became turbid to stop dropping, and the solution was placed in a refrigerator to stand still overnight. The filter residue was parent molecule BIIB021. 6-Chloro-9-[(4-methoxy-3, 5-dimethyl-2-pyridyl)methyl]-9H-purin-2-amine (BIIB021):Light yellow solid; Yield: 77percent;Weigh the 2-amino-6-chloropurine 10mmol, anhydrous potassium carbonate 12mmol, measure 25mL DMSO into a 50mL round bottom flask, and raise the temperature in the oil bath to 48°C.The reaction was stirred for 30 min; 11 mmol of 2-chloromethyl-3, 5-dimethylpyridine hydrochloride was weighed and added to the above reaction solution in 3 portions at intervals of 30 min. After reaction at 48 °C for 10 h, the temperature was set to 22 ° C and stirred for 2 h.After the reaction is completed, the reaction solution is suction-filtered, and the filtrate is retained; a mixed solution with a volume ratio of water:isopropanol = 1:1 is added to the filtrate, until the solution becomes turbid, and the solution is added dropwise. The solution is left in the refrigerator at rest overnight, and the filter is filtered.
BIIB 021 an orally available, fully synthetic small-molecule inhibitor of the heat shock protein Hsp90. Studies show that BIIB 021 adminisitration led to degradation of Hsp90 client proteins measured in tumor tissue and resulted in the inhibition of tumor growth in several human tumor xenograft models.
Computed Properties
Molecular Weight:318.76
XLogP3:1.9
Hydrogen Bond Donor Count:1
Hydrogen Bond Acceptor Count:6
Rotatable Bond Count:3
Exact Mass:318.0995868
Monoisotopic Mass:318.0995868
Topological Polar Surface Area:91.7
Heavy Atom Count:22
Complexity:388
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes
Recommended Suppliers of [6-Chloro-9-(4-methoxy-3,5-dimethylpyridin-2-ylmethyl)-9H-purin-2-yl]amine
-
CN
5 YRS
Business licensedTrader Supplier of Intermediates,Building blocks,API,Silicones,Peptides,Lab chemicals,Biochemicals,Pharmaceuticals,Screening Compounds,Food Additives -
US
6 YRS
Business licensed Certified factoryManufactory Supplier of Coenzymes,Inhibito,Enzymes,Zymogens,Substrates
Latest News on [6-Chloro-9-(4-methoxy-3,5-dimethylpyridin-2-ylmethyl)-9H-purin-2-yl]amine
- BMS Over $900 Million to Help Develop Potential 'Best-in-class' SHP2 Inhibitors
- AbbVie's blockbuster product for atopic dermatitis, Upadacitinib, has been approved for marketing in the EU and Japan
- Designing peptide inhibitors for possible COVID-19 treatments
- Chinese scientists discover the inhibitors of SARS-CoV-2
Learn More Other Chemicals
-
Dabrafenib
1195765-45-7
-
BOC-VAL-VAL-OH
69209-73-0
-
BMS 303141
943962-47-8
-
(2S)-2-[[(2S)-2-[[2-[[2-[[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]acetyl]amino]acetyl]amino]-3-phenylpropanoyl]amino]-4-methylsulfanylbutanamide Formula
60117-17-1
-
(2S)-2-acetamido-6-amino-N-[(2S)-2-amino-3-methylbutanoyl]-N-propylhexanamide Formula
57899-96-4
-
1-(6-methoxy-1,3-benzothiazol-2-yl)-3-phenylurea Formula
26130-02-9
-
L-Tyrosyl-L-phenylalanine Structure
17355-11-2
-
C-REACTIVE PROTEIN FRAGMENT 77-82 Structure
130349-01-8
-
What is Sildenafil
139755-83-2
-
What is Dacomitinib
1110813-31-4
[6-Chloro-9-(4-methoxy-3,5-dimethylpyridin-2-ylmethyl)-9H-purin-2-yl]amine
SDSRequest for Quotation